Stay updated with breaking news from Headache Alliance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This chronic disease primarily affects people of working age, and in addition to the social cost, it has a significant economic cost. Yet there is insufficient recognition of the condition at an EU level.
New Migraine Friendly Workplace Stamp developed by the European Migraine & Headache Alliance recognises organizations who support their employees who suffer from migraine - a severe and debilitating
Interim data presented at the European Academy of Neurology 2022 shows that 54.7% of patients in the study had their monthly-migraine-days reduced by 50% or more over the six-month period from the start of treatment.
Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab) - read this article along with other careers information, tips and advice on BioSpace
Interim data presented at the European Academy of Neurology 2022 shows that 54.7% of patients in the study had their monthly-migraine-days reduced by 50% or more over the six-month period from the start